Barclays »

United Therapeutics Corporation shares owned by Barclays

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Barclays

Quarter filed Position value Share count Share price at filing
2013-03-31 $16M 255k 60.89
2012-12-31 $13M 240k 53.41
2012-09-30 $46M 815k 55.88
2012-03-31 $14M 297k 47.13
2011-12-31 $48M 1.0M 47.25
2011-09-30 $38M 1.0M 37.49
2011-06-30 $80M 1.4M 55.10
2011-03-31 $29M 434k 67.02
2010-12-31 $59M 938k 63.22

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
FMR
AQR Capital Management
Geode Capital Management
Citadel Advisors
Citigroup
Henderson Group
Hanna Zanoni
Dimensional Fund Advisors
Morgan Stanley
LSV Asset Management
Pacer Advisors

View all funds holding United Therapeutics Corporation